The Role of Cytokines in Apparently Normal Pregnancies
Withdrawn
- Conditions
- Pregnancy
- Registration Number
- NCT01098214
- Lead Sponsor
- NYU Langone Health
- Brief Summary
To provide rigorous, detailed normative data for diagnostics and comparative studies, to determine relationships between cytokine levels (and other biomarkers) and clinical data, and gain further insight into the pro-/anti-inflammatory cytokine profile of normal midtrimester amniotic fluid.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- Age over 18
- Pregnancies between 15-25 weeks gestation.
- Able to provide informed consent.
- No apparent major sonographic abnormality.
Exclusion Criteria
- Any major fetal anomaly
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What cytokine profiles are associated with normal midtrimester amniotic fluid in pregnancy?
How do pro-inflammatory and anti-inflammatory cytokines interact during healthy pregnancies?
What biomarkers correlate with cytokine levels in amniotic fluid for pregnancy diagnostics?
Are there adverse events linked to cytokine imbalances in normal pregnancies?
What molecular targets could modulate cytokine balance for pregnancy-related therapies?